Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population
4.528m
GDP (2002)
NOK1,525.984bn
Health expenditure (2001)
Health expenditure as proportion of GDP
Size of pharmaceutical market (retail price)
Proportion of GDP spent on pharmaceuticals
Pharmaceuticals as a proportion of health spend
Pharmaceutical market growth rate (2003)
Local currency (NOK)
Krone (NOK)
Summary: Norway
Recent abolition of the reference price system will maintain Norwegian pharmaceutical prices at the EU’s average. The government is in dispute with the European Free Trade Association over the time taken to make reimbursement decisions. This year’s liberalisation of the wholesale and pharmacy sectors will have long-term implications on prices and margins.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
15/11/2003
Competition Authority raids pharmacies and wholesalers
Related Items